Accuray | ARAY - Operating Profit

Stock Price
0.54
Daily Change
-0.02 -3.08%
Monthly
-33.90%
Yearly
-74.63%
Q1 Forecast
0.52

Accuray reported $4.71M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -9.97M 1.12M Feb/2025
Artivion USD 4.39M 2.12M Sep/2024
AtriCure USD 2.49M 2.28M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Hologic USD 237M 16M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Orthofix International USD -84.62M 65.72M Dec/2024
Surmodics USD -5.64M 276K Sep/2024
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Trinity Biotech USD -509K 6.27M Sep/2025